AGP Picks
View all

The LATAM Ledger
Provided by AGP

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 5, 2026

Reflex Advanced Announces Private Placement of up to C$1,500,000 of Unsecured Convertible Debentures
Aug. 5, 2026

Reflex Advanced Announces Private Placement of up to C$1,500,000 of Unsecured Convertible Debentures

Indeterminate GlobeNewswire
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
Aug. 5, 2026

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
Aug. 5, 2026

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Indeterminate GlobeNewswire
Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
Aug. 5, 2026

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Indeterminate GlobeNewswire
Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz
Aug. 5, 2026

Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz

Indeterminate GlobeNewswire
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
Aug. 5, 2026

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire
Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
Aug. 5, 2026

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
Aug. 5, 2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Indeterminate GlobeNewswire
BioCryst Reports Second Quarter 2026 Financial Results
Aug. 5, 2026

BioCryst Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Entrada Therapeutics Reports Second Quarter 2026 Financial Results
Aug. 5, 2026

Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
Aug. 5, 2026

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire
Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue
Aug. 5, 2026

Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue

Indeterminate GlobeNewswire
Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow
Aug. 5, 2026

Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow

Indeterminate GlobeNewswire
Lahontan Drills 12.2m Grading 1.25 g/t Au Oxide at Calvada East
Aug. 5, 2026

Lahontan Drills 12.2m Grading 1.25 g/t Au Oxide at Calvada East

Indeterminate GlobeNewswire
Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy
Aug. 5, 2026

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy

Indeterminate GlobeNewswire
Telix to Host R&D Day in New York City on September 22, 2026
Aug. 5, 2026

Telix to Host R&D Day in New York City on September 22, 2026

Indeterminate GlobeNewswire
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Aug. 5, 2026

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Indeterminate GlobeNewswire
Discovery Reports Positive Drill Results at Key Growth Projects, Resource Estimates for Dome and TVZ on Track for Late 2026
Aug. 5, 2026

Discovery Reports Positive Drill Results at Key Growth Projects, Resource Estimates for Dome and TVZ on Track for Late 2026

Indeterminate GlobeNewswire
Kilbourne Graphite Advances Towards Commercialization with Global Refractory Manufacturer
Aug. 5, 2026

Kilbourne Graphite Advances Towards Commercialization with Global Refractory Manufacturer

Indeterminate GlobeNewswire
Nano Labs Approved as a Validator Node on Canton Network
Aug. 5, 2026

Nano Labs Approved as a Validator Node on Canton Network

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The LATAM Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.